Related references
Note: Only part of the references are listed.The pharmacokinetics and the pharmacodynamics of cannabinoids
Catherine J. Lucas et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: Impact of drug and fixed-dose ratio
David R. Maguire et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cannabidiol for drug-resistant seizures in the Dravet syndrome
Craig Mellis
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2018)
Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain
Epifanio Mondello et al.
JOURNAL OF PAIN RESEARCH (2018)
Low back pain, obesity, and inflammatory markers: exercise as potential treatment
Isabela Maia da Cruz Fernandes et al.
JOURNAL OF EXERCISE REHABILITATION (2018)
Risk factors for opioid-induced respiratory depression and failure to rescue: a review
Kapil Gupta et al.
CURRENT OPINION IN ANESTHESIOLOGY (2018)
Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain
Matthew B. Yuill et al.
MOLECULAR PAIN (2017)
Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis
Suzanne Nielsen et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Perioperative Patient Beliefs Regarding Potential Effectiveness of Marijuana (Cannabinoids) for Treatment of Pain A Prospective Population Survey
Yury Khelemsky et al.
REGIONAL ANESTHESIA AND PAIN MEDICINE (2017)
Crash Fatality Rates After Recreational Marijuana Legalization in Washington and Colorado
Jayson D. Aydelotte et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2017)
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease
Nicola Barrie et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2017)
Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines
Ana Lucia Arellano et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Cannabis and Pain: A Clinical Review
Kevin P. Hill et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Opioid and cannabinoid synergy in a mouse neuropathic pain model
Nicholas P. Kazantzis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake
Matthew N. Newmeyer et al.
CLINICAL CHEMISTRY (2016)
The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study
Simon Haroutounian et al.
CLINICAL JOURNAL OF PAIN (2016)
Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity
Ricardo Jorge Dinis-Oliveira
DRUG METABOLISM REVIEWS (2016)
Opioids Out, Cannabis In Negotiating the Unknowns in Patient Care for Chronic Pain
Esther K. Choo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain
Herbert H. Seltzman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease
Barth Wilsey et al.
JOURNAL OF PAIN (2016)
The effects of Δ9-tetrahydrocannabinol on the dopamine system
Michael A. P. Bloomfield et al.
NATURE (2016)
The endocannabinoid system and neuropathic pain
Rafael Maldonado et al.
PAIN (2016)
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain
Natalia Malek et al.
PHARMACOLOGICAL RESEARCH (2016)
Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis) A systematic review of randomized controlled trials
M. -A. Fitzcharles et al.
SCHMERZ (2016)
Non-opioid analgesics: Novel approaches to perioperative analgesia for major spine surgery
Lauren K. Dunn et al.
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY (2016)
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal
Liting Deng et al.
BIOLOGICAL PSYCHIATRY (2015)
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Sumner Burstein
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Medicinal Chemistry of Cannabinoids
V. Kiran Vemuri et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence
Bjorn Jensen et al.
CURRENT PAIN AND HEADACHE REPORTS (2015)
Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ...
Eric P. Baron
HEADACHE (2015)
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems A Clinical Review
Kevin P. Hill
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Peripherally Restricted Cannabinoids for the Treatment of Pain
E. Alfonso Romero-Sandoval et al.
PHARMACOTHERAPY (2015)
Evidence that the presence of psychosis in non-psychotic disorder is environment-dependent and mediated by severity of non-psychotic psychopathology
S. Guloksuz et al.
PSYCHOLOGICAL MEDICINE (2015)
Opioids for low back pain
Richard A. Deyo et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Opioids for low back pain
Richard A. Deyo et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Neuropathic pain in the general population: A systematic review of epidemiological studies
O. van Hecke et al.
PAIN (2014)
Anxiety mediates the association between cannabis use and attenuated positive psychotic symptoms
Lauren E. Reeves et al.
PSYCHIATRY RESEARCH (2014)
Medical Marijuana for Failed Back Surgical Syndrome: A Viable Option for Pain Control or an Uncontrolled Narcotic? Response
Sunil K. Aggarwal et al.
PM&R (2014)
Cannabis Effects on Driving Skills
Rebecca L. Hartman et al.
CLINICAL CHEMISTRY (2013)
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis
Michael G. Serpell et al.
JOURNAL OF NEUROLOGY (2013)
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
Barth Wilsey et al.
JOURNAL OF PAIN (2013)
Weed or Wheel! fMRI, Behavioural, and Toxicological Investigations of How Cannabis Smoking Affects Skills Necessary for Driving
Giovanni Battistella et al.
PLOS ONE (2013)
The Pharmacologic and Clinical Effects of Medical Cannabis
Laura M. Borgelt et al.
PHARMACOTHERAPY (2013)
Evaluation of the analgesic efficacy of AZD1940, a novel cannabinoid agonist, on post-operative pain after lower third molar surgical removal
Jarkko Kalliomaki et al.
SCANDINAVIAN JOURNAL OF PAIN (2013)
The Endocannabinoid System, Cannabinoids, and Pain
Perry G. Fine et al.
RAMBAM MAIMONIDES MEDICAL JOURNAL (2013)
Interactions between μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists in Rhesus Monkeys: Antinociception, Drug Discrimination, and Drug Self-Administration
David R. Maguire et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain
Julia M. Adam et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk
John Charles A. Lacson et al.
CANCER (2012)
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
Russell K. Portenoy et al.
JOURNAL OF PAIN (2012)
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
W. Notcutt et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee
John P. Huggins et al.
PAIN (2012)
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
Roger G. Pertwee
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking
Erik B. Oleson et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Cannabis, a complex plant: different compounds and different effects on individuals
Zerrin Atakan
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2012)
Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis
Mark Asbridge et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions
Rebecca D. Crean et al.
JOURNAL OF ADDICTION MEDICINE (2011)
The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects
Steven G. Kinsey et al.
NEUROPHARMACOLOGY (2011)
CB2: a cannabinoid receptor with an identity crisis
Brady K. Atwood et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The endocannabinoid system as a target for the treatment of neurodegenerative disease
Emma L. Scotter et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Mark A. Ware et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain
Xiao Hong Yu et al.
PAIN (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
Praveen Anand et al.
BRAIN RESEARCH REVIEWS (2009)
Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain
Kay Ahn et al.
CHEMISTRY & BIOLOGY (2009)
Cannabis Coadministration Potentiates the Effects of Ecstasy on Heart Rate and Temperature in Humans
G. J. Dumont et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
The Endocannabinoid System and Pain
Josee Guindon et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
Ronald J. Ellis et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint
Stefan W. Toennes et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2008)
Nabilone for the treatment of pain in fibromyalgia
Ryan Quinlan Skrabek et al.
JOURNAL OF PAIN (2008)
Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy
Sanjeet Narang et al.
JOURNAL OF PAIN (2008)
A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain
Barth Wilsey et al.
JOURNAL OF PAIN (2008)
Modelling of the concentration-effect relationship of THC on central nervous system parameters and heart rate - insight into its mechanisms of action and a tool for clinical research and development of cannabinoids
A. Strougo et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Jane E. Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial
Turo J. Nurmikko et al.
PAIN (2007)
Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers
Mark Wallace et al.
ANESTHESIOLOGY (2007)
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone:: A potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration
Edward K. Dziadulewicz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
Nitin Agarwal et al.
NATURE NEUROSCIENCE (2007)
Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors
Aleksandra Ellert-Miklaszewska et al.
BRAIN RESEARCH (2007)
Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis
Cristina Benito et al.
JOURNAL OF NEUROSCIENCE (2007)
Cannabis in painful HIV-associated sensory neuropathy - A randomized placebo-controlled trial
D. I. Abrams et al.
NEUROLOGY (2007)
Effects of marijuana smoking on pulmonary function and respiratory complications - A systematic review
Jeanette M. Tetrault et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Human cannabinoid pharmacokinetics
Marilyn A. Huestis
CHEMISTRY & BIODIVERSITY (2007)
Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist
Fumimasa Amaya et al.
PAIN (2006)
Effects of nabilone, a synthetic cannabinoid, on postoperative pain
Pierre Beaulieu
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2006)
Molecular and cellular basis of rheumatoid joint destruction
Emmanuel Karouzakis et al.
IMMUNOLOGY LETTERS (2006)
The association between marijuana smoking and lung cancer - A systematic review
Reena Mehra et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management
A Holdcroft et al.
ANESTHESIOLOGY (2006)
Δ9-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain
W. Seeling et al.
ANAESTHESIST (2006)
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
DR Blake et al.
RHEUMATOLOGY (2006)
Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Δ9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract
T Nadulski et al.
THERAPEUTIC DRUG MONITORING (2005)
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
DJ Rog et al.
NEUROLOGY (2005)
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw
B Costa et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation
B Costa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074):: A novel cannabinoid CB1/CB2 receptor partial agonist with antihyperalgesic and antiallodynic effects
J De Vry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
DC D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial
JS Berman et al.
PAIN (2004)
Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens
VM Pickel et al.
NEUROSCIENCE (2004)
Lack of analgesic efficacy of oral δ-9-tetrahydrocannabinol in postoperative pain
DJ Buggy et al.
PAIN (2003)
Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats
G Lim et al.
PAIN (2003)
Pharmacokinetics and pharmacodynamics of cannabinoids
F Grotenhermen
CLINICAL PHARMACOKINETICS (2003)
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
DT Wade et al.
CLINICAL REHABILITATION (2003)
In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation
PVN Challapalli et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Cloning and molecular characterization of the rat CB2 cannabinoid receptor
SM Brown et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
Cognitive functioning of long-term heavy cannabis users seeking treatment
N Solowij et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Pharmacology and effects of cannabis: a brief review
CH Ashton
BRITISH JOURNAL OF PSYCHIATRY (2001)
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
AM Malfait et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances
SW Hwang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Cannabinoids modulate pain by multiple mechanisms of action
JD Richardson
JOURNAL OF PAIN (2000)
Share Paper
